213 related articles for article (PubMed ID: 9060706)
21. Modulation of macrophage infiltration and inflammatory activity by the phosphatase SHP-1 in virus-induced demyelinating disease.
Christophi GP; Hudson CA; Panos M; Gruber RC; Massa PT
J Virol; 2009 Jan; 83(2):522-39. PubMed ID: 18987138
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease. Evidence for a CD4+ T cell-mediated pathology.
Pope JG; Karpus WJ; VanderLugt C; Miller SD
J Immunol; 1996 May; 156(10):4050-8. PubMed ID: 8621948
[TBL] [Abstract][Full Text] [Related]
23. Molecular pathogenesis of Theiler's murine encephalomyelitis virus-induced demyelinating disease in mice.
Lipton HL; Jelachich ML
Intervirology; 1997; 40(2-3):143-52. PubMed ID: 9450231
[TBL] [Abstract][Full Text] [Related]
24. Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2(b) mice inhibits resistance to virus-induced demyelination.
Lin X; Njenga MK; Johnson AJ; Pavelko KD; David CS; Pease LR; Rodriguez M
J Virol; 2002 Aug; 76(15):7799-811. PubMed ID: 12097592
[TBL] [Abstract][Full Text] [Related]
25. Spontaneous CNS remyelination in beta 2 microglobulin-deficient mice following virus-induced demyelination.
Miller DJ; Rivera-Quiñones C; Njenga MK; Leibowitz J; Rodriguez M
J Neurosci; 1995 Dec; 15(12):8345-52. PubMed ID: 8613767
[TBL] [Abstract][Full Text] [Related]
26. Fibrin deposition in the central nervous system correlates with the degree of Theiler's murine encephalomyelitis virus-induced demyelinating disease.
Inoue A; Koh CS; Yamazaki M; Yanagisawa N; Ishihara Y; Kim BS
J Neuroimmunol; 1997 Aug; 77(2):185-94. PubMed ID: 9258249
[TBL] [Abstract][Full Text] [Related]
27. Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection.
Chamorro M; Aubert C; Brahic M
J Virol; 1986 Mar; 57(3):992-7. PubMed ID: 3951022
[TBL] [Abstract][Full Text] [Related]
28. Gamma interferon is critical for resistance to Theiler's virus-induced demyelination.
Rodriguez M; Pavelko K; Coffman RL
J Virol; 1995 Nov; 69(11):7286-90. PubMed ID: 7474155
[TBL] [Abstract][Full Text] [Related]
29. The balance between persistent virus infection and immune cells determines demyelination.
Rodriguez M; Pavelko KD; Njenga MK; Logan WC; Wettstein PJ
J Immunol; 1996 Dec; 157(12):5699-709. PubMed ID: 8955224
[TBL] [Abstract][Full Text] [Related]
30. A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VP1(233-244).
Yauch RL; Kim BS
J Immunol; 1994 Nov; 153(10):4508-19. PubMed ID: 7525707
[TBL] [Abstract][Full Text] [Related]
31. CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology.
Begolka WS; Haynes LM; Olson JK; Padilla J; Neville KL; Dal Canto M; Palma J; Kim BS; Miller SD
J Neurovirol; 2001 Oct; 7(5):409-20. PubMed ID: 11582513
[TBL] [Abstract][Full Text] [Related]
32. Expression of L* protein of Theiler's murine encephalomyelitis virus in the chronic phase of infection.
Asakura K; Murayama H; Himeda T; Ohara Y
J Gen Virol; 2007 Aug; 88(Pt 8):2268-2274. PubMed ID: 17622631
[TBL] [Abstract][Full Text] [Related]
33. Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis.
Lindsley MD; Patick AK; Prayoonwiwat N; Rodriguez M
Mayo Clin Proc; 1992 Sep; 67(9):829-38. PubMed ID: 1434926
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis.
Rodriguez M; Pavelko KD; McKinney CW; Leibowitz JL
J Immunol; 1994 Oct; 153(8):3811-21. PubMed ID: 7930598
[TBL] [Abstract][Full Text] [Related]
35. Theiler's murine encephalomyelitis virus 3D RNA polymerase: its expression in the CNS and the specific immune response generated in persistently infected mice.
Johnston IC; Usherwood EJ; Nash AA; Brown TD
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2765-77. PubMed ID: 7595384
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the role of delayed-type-hypersensitivity responses to myelin in the pathogenesis of Theiler's virus-induced demyelinating disease.
Borrow P; Welsh CJ; Tonks P; Dean D; Blakemore WF; Nash AA
Immunology; 1998 Apr; 93(4):478-84. PubMed ID: 9659218
[TBL] [Abstract][Full Text] [Related]
37. Macrophage antigen-1 positive cells are essential in the defense against Theiler's virus strain GD VII infection in the spinal cord.
Kohanawa M; Asano M; Minagawa T; Nakane A
Microb Pathog; 1997 Jul; 23(1):33-8. PubMed ID: 9250778
[TBL] [Abstract][Full Text] [Related]
38. Chimeric Theiler's virus with altered tropism for the central nervous system.
Jarousse N; Fiette L; Grant RA; Hogle JM; McAllister A; Michiels T; Aubert C; Tangy F; Brahic M; Peña Rossi C
J Virol; 1994 May; 68(5):2781-6. PubMed ID: 8151749
[TBL] [Abstract][Full Text] [Related]
39. Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus.
Massa PT; Ropka SL; Saha S; Fecenko KL; Beuler KL
J Virol; 2002 Aug; 76(16):8335-46. PubMed ID: 12134038
[TBL] [Abstract][Full Text] [Related]
40. Replacement of loop II of VP1 of the DA strain with loop II of the GDVII strain of Theiler's murine encephalomyelitis virus alters neurovirulence, viral persistence, and demyelination.
Wada Y; McCright IJ; Whitby FG; Tsunoda I; Fujinami RS
J Virol; 1998 Sep; 72(9):7557-62. PubMed ID: 9696853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
